• English
  • Korean
  • Chinese
表紙
市場調査レポート - 242225

世界の動物医療・診断市場

Global Markets for Animal Therapeutics and Diagnostics

発行 BCC Research
出版日 ページ情報 英文 227 Pages
価格
世界の動物医療・診断市場 Global Markets for Animal Therapeutics and Diagnostics
出版日: 2012年05月24日 ページ情報: 英文 227 Pages
担当者のコメント
世界の動物医療、飼料添加物、診断用製品市場を分析しており、また家畜とペットも含んでいる包括的なレポートです
概要

動物の医療および診断市場は2008年の250億ドルから、2011年には300億ドルの市場規模へと成長しました。2011年から2016年までは7.2%の年平均成長率で推移し、2016年には420億ドルを超える規模に成長すると予測されています。

当レポートでは、世界の動物医療・診断市場の現状と見通しについて調査分析し、4種の製品区分(ワクチン・医薬品・飼料添加物・診断製品)における主要製品の概要、市場規模実績・予測(〜2016年)、市場影響因子の分析、主要企業のプロファイルなどをまとめ、概略以下の構成でお届けいたします。

第1章 イントロダクション

第2章 サマリー

第3章 産業概要

  • 動物解剖学・生理学
  • 動物個体数:米国
  • 動物個体数:国別
  • コンパニオンアニマルの疾患
  • 食用動物の疾患
  • 人畜共通疾患

第4章 市場影響因子

  • 抗生剤の利用と食用動物における抵抗
  • プロバイオティクス
  • 法規制上の課題
  • ドラッグデリバリーの進歩
  • アニマルヘルスにおけるバイオテクノロジー
  • コンパニオンペットの飼育動向
  • 動物の医療保険
  • 動物の肥満
  • 獣医サービス産業における需要
  • 高度医療処置
  • 国際的課題・動向

第5章 動物用ワクチン

  • 概要
  • 製品概要
  • コンパニオンアニマル用ワクチン
  • 食用動物用ワクチン
  • 市場分析・総論

第6章 動物用医薬品

  • 概要
  • 製品概要
  • 市場分析・総論

第7章 動物用飼料添加物

  • 概要
  • 製品概要
  • 栄養補助剤
  • ビタミン・ミネラル
  • 市場分析・総論

第8章 動物用診断製品

  • 概要
  • 製品概要
  • 市場分析・総論

第9章 市場サマリー

  • 動物医療・診断市場:総市場の分析
  • 産業関連事業者:タイプ別

第10章 企業プロファイル

第11章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Abstract

REPORT HIGHLIGHTS

The total market for animal therapeutics and diagnostics was $30 billion in 2011, up from $25 billion in 2008. By 2016, this market is likely to exceed $42 billion, with a five-year compound annual growth rate (CAGR) of 7.2% from 2011 through 2016.

The pharmaceutical segment accounts for the largest percentage of revenue with nearly 48%. Sales for this segment reached $14.3 billion in 2011 and are expected to increase to nearly $21.0 billion by 2016, a CAGR of 7.5%.

Feed additives represent the second-largest market segment, with a total market value of $8.3 billion in 2011. This segment is forecast to grow at a CAGR of 5% during the next five years and reach $10.6 billion by 2016.

image1

REPORT SCOPE

INTRODUCTION

STUDY GOALS AND OBJECTIVES

This BCC Research report, Global Markets for Animal Therapeutics and Diagnostics, provides an overview of products included in this market and detailed market analyses and competitive environments. The study includes information about significant products, players, issues and trends, and other information affecting the animal therapeutic and diagnostic market.

REASONS FOR DOING THE STUDY

The animal health industry is responsible for maintaining the health and productivity of the over 3.3 billion livestock and 16 billion poultry worldwide and ensuring the wholesomeness and abundance of the food they produce. In addition, the industry must also cater to the health and well being of companion animals. Despite this, the human healthcare market is 35 times larger than the combined market for all nonhuman species. The reality is that the global animal health market is very complex, operating under stringent and increasingly strict regulations similar to those for human health, yet the market opportunities are considerably smaller. In an increasingly risky environment for new product development, the difference between success and failure in the future usually lies in successfully identifying the next growth segment, developing the right product candidates and being the first to market. Despite all these risks, the industry continues to grow.

In contrast to human blockbuster-oriented pharmaceuticals, animal health is dominated by large numbers of products with small revenues. Although there are hundreds of products involved in this market, only about 30 products have sales exceeding $100 million per year. However, the industry continues to forge on. The fastest growing therapeutic categories are in the area of companion animals, specifically in the arthritis and pain segments of the market.

A challenging aspect of the market is within the animal food industry as consumers continue to express concern about the conditions under which their daily food is produced. Consumers are becoming more health conscious and demanding healthy and balanced diets. By implementing a feeding plan that provides vitamins and supplements, consumers enjoy additional nutritional benefits. Additionally, healthy feeding results in minimized impact on the environment.

INTENDED AUDIENCE

The information within this report is directed at the business and industry professional and is specifically designed to aid in the explanation, direction and future of animal health markets. The report focuses on providing the reader with an understanding of trends in the industry, market segments, market forecasts, leading players, market drivers and inhibitors.

SCOPE OF REPORT

This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the animal therapeutic and diagnostic market. The geographical scope of this study is worldwide, with special interest for markets, trends and statistics by key geographical regions such as the United States, European countries and Brazil, Japan and Australia. The report identifies markets in four segments: vaccines, pharmaceuticals, feed additives and diagnostics. For the purpose of this study, diagnostics includes products that are used at the point of care and are considered rapid tests or kits. Each market segment provides detailed information based on product categories, use of products, forecasts and competitive analyses.

INFORMATION SOURCES

The information for this BCC report was obtained through primary and secondary data-collection methods. Primary methods included interviews with approximately 40 key executives, product managers and clinical specialists involved in the animal health industry. Secondary methods included published literature in the area of animal science and veterinary services, investment reports, company literature, and various animal health journals.

All market data pertains to the global market at the manufacturers' level. Data are expressed in current U.S. dollars. The base year of the report is 2011, with historical data provided for 2008 through 2010, and forecast data provided for 2012 and 2016. Historical, base year and forecast data are provided for each market segment of the report. Competitor market share estimates are provided for each market segment for the 2011 base year.

Although this study provides information on a variety of products used to treat animals, it does not include a comprehensive list of all products available.

ANALYST CREDENTIALS

Melissa Elder is an experienced healthcare market analyst specializing in prescription and over-the-counter pharmaceuticals, medical devices, and emerging healthcare technologies. Ms. Elder has nearly 20 years of experience in the healthcare industry, specializing in market research for the past 14 years. This experience has given her substantial insight into pharmaceutical market analysis. Her work in the medical community, including emergency room medical training and healthcare information system coordination, has enhanced her ability to provide insight into many healthcare markets.

Table of Contents

Chapter- 1: INTRODUCTION - Complimentary

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • INTENDED AUDIENCE
  • SCOPE OF REPORT
  • INFORMATION SOURCES
  • RELATED BCC RESEARCH REPORTS
  • ANALYST CREDENTIALS
  • BCC ON-LINE SERVICES
  • DISCLAIMER

Chapter- 2: SUMMARY

  • LEADING PRODUCTS AND MANUFACTURERS

Chapter- 3: INDUSTRY OVERVIEW

  • ANIMAL ANATOMY AND PHYSIOLOGY
  • ANIMAL POPULATIONS IN THE UNITED STATES
  • ANIMAL POPULATIONS BY COUNTRY
  • COMPANION ANIMAL DISEASES
  • FOOD ANIMAL DISEASES
  • ZOONOTIC DISEASES

Chapter- 4: ISSUES AFFECTING THE MARKET

  • ANTIBIOTIC USE AND RESISTANCE IN FOOD ANIMALS
  • PROBIOTICS
  • LEGAL AND REGULATORY ISSUES
  • ADVANCES IN DRUG DELIVERY
  • BIOTECHNOLOGY IN ANIMAL HEALTH
  • TRENDS IN COMPANION PET OWNERSHIP
  • ANIMAL HEALTH INSURANCE
  • ANIMAL OBESITY
  • DEMAND IN THE VETERINARY SERVICE INDUSTRY
  • ADVANCED MEDICAL PROCEDURES
  • INTERNATIONAL ISSUES AND TRENDS

Chapter- 5: ANIMAL VACCINES

  • OVERVIEW
  • PRODUCT DESCRIPTION
  • COMPANION ANIMAL VACCINES
  • FOOD ANIMAL VACCINES
  • MARKET ANALYSIS AND CONCLUSIONS

Chapter- 6: ANIMAL PHARMACEUTICAL PRODUCTS

  • OVERVIEW
  • PRODUCT DESCRIPTION
  • MARKET ANALYSIS AND CONCLUSIONS

Chapter- 7: ANIMAL FEED ADDITIVES

  • OVERVIEW
  • PRODUCT DESCRIPTION
  • NUTRITIONAL SUPPLEMENTS
  • VITAMINS AND MINERALS
  • MARKET ANALYSIS AND CONCLUSION

Chapter- 8: ANIMAL DIAGNOSTICS

  • OVERVIEW
  • PRODUCT DESCRIPTION
  • MARKET ANALYSIS AND CONCLUSION

Chapter- 9: MARKET SUMMARY

  • TOTAL ANIMAL THERAPEUTICS AND DIAGNOSTIC MARKET ANALYSIS
  • INDUSTRY PARTICIPANTS BY TYPE
  • Table 64 : TOTAL MARKET ANALYSIS FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY PRODUCT SEGMENT, THROUGH 2016
  • Figure 37 : TOTAL MARKET ANALYSIS FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY PRODUCT SEGMENT, 2008-2016

Chapter- 10: COMPANY PROFILES

  • ABAXIS INC.
  • AUV VETERINARY COOPERATIVE
  • BASF ANIMAL NUTRITION (BASF SE)
  • BAYER ANIMAL HEALTH
  • BOEHRINGER INGELHEIM CORP.
  • DSM NUTRITIONAL PRODUCTS LTD.
  • ELANCO ANIMAL HEALTH
  • EVONIK INDUSTRIES AG
  • HESKA CORP.
  • IDEXX LABORATORIES INC.
  • MERCK & CO. INC.
  • MOSAIC CO. (THE)
  • NOVARTIS ANIMAL HEALTH INC.
  • NOVUS INTERNATIONAL INC.
  • PFIZER ANIMAL HEALTH
  • SANOFI
  • VIRBAC SA

Chapter- 11: APPENDICES

  • APPENDIX I: LEADING MANUFACTURES AND AFFILIATED COMPANIES
  • APPENDIX II: RELEVANT ASSOCIATIONS AND ORGANIZATIONS

List of Tables

  • Summary Table : TOTAL ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY MAJOR SEGMENT, THROUGH 2016
  • Table 1 : GESTATION PERIODS OF SELECT COMMON SPECIES
  • Table 2 : LIFESPAN OF COMMON PET AVIAN SPECIES
  • Table 3 : U.S. HOUSEHOLD STATISTICS FOR COMPANION ANIMALS, 2011
  • Table 4 : U.S. ESTIMATED POPULATIONS OF COMPANION ANIMALS, 2011
  • Table 5 : U.S. REPORTED POPULATION OF FOOD PRODUCTION ANIMALS, 2005 AND 2010*
  • Table 6 : DOG (CANINE) POPULATION BY COUNTRY, 2010
  • Table 7 : CAT (FELINE) POPULATION BY COUNTRY
  • Table 8 : HORSE (EQUINE) POPULATION BY COUNTRY
  • Table 9 : CATTLE (BOVINE) POPULATION BY COUNTRY
  • Table 10 : PIG/HOG (SWINE) POPULATION BY COUNTRY
  • Table 11 : SHEEP/LAMB POPULATION BY COUNTRY
  • Table 12 : GOAT POPULATION BY COUNTRY
  • Table 13 : COUNTRIES WITH THE HIGHEST REPORTED ANIMAL POPULATIONS
  • Table 14 : COMMON EXAMPLES OF ZOONOTIC DISEASES
  • Table 15 : CURRENT LIST OF APPROVED ANTIBIOTICS/ANTIMICROBIALS USED IN FOOD-PRODUCING ANIMALS IN THE UNITED STATES
  • Table 16 : ANTIMICROBIAL DRUG USE AND SALES IN FOOD-PRODUCING ANIMALS, 2010
  • Table 17 : APPA NATIONAL PET OWNERS SURVEY, 2011-2012 BASIC ANNUAL EXPENSES FOR DOGS AND CATS
  • Table 18 : DOG INSURANCE PLAN COMPARISONS, UNITED STATES
  • Table 19 : CAT INSURANCE PLAN COMPARISONS, UNITED STATES
  • Table 20 : ESTIMATED NUMBER OF VETERINARIAN PRACTICES IN THE UNITED STATES BY TYPE OF PRACTICE, 2011
  • Table 21 : ESTIMATED NUMBER OF VETERINARIAN'S IN THE UNITED STATES BY YEAR, 2007 - 2011
  • Table 22 : ESTIMATED POPULATIONS OF COMPANION ANIMALS IN JAPAN AND AUSTRALIA, 2010
  • Table 23 : ESTIMATED POPULATIONS OF FARM ANIMALS IN ARGENTINA, BRAZIL AND INDIA, 2010
  • Table 24 : VACCINES BY TARGET SPECIES AND PROVIDERS
  • Table 25 : MARKET ANALYSIS FOR ANIMAL VACCINES BY USE, THROUGH 2016
  • Table 26 : ESTIMATED REVENUES FOR ANIMAL VACCINES BY TYPE, THROUGH 2016
  • Table 27 : DISTRIBUTION OF REVENUES FOR ANIMAL VACCINES BY WORLD REGION, 2011
  • Table 28 : COMPETITIVE SUMMARY FOR ANIMAL VACCINES BY COMPETITOR REVENUE, 2011
  • Table 29 : ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES AND PROVIDERS
  • Table 30 : ANTI-INFECTIVES BY TARGET SPECIES AND PROVIDERS
  • Table 31 : ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES AND PROVIDERS
  • Table 32 : METABOLIC DRUGS BY TARGET SPECIES AND PROVIDERS
  • Table 33 : PARASITICIDES BY TARGET SPECIES AND PROVIDERS
  • Table 34 : OTHER PHARMACEUTICALS BY TARGET SPECIES AND PROVIDERS
  • Table 35 : MARKET ANALYSIS FOR ALLERGY AND RESPIRATORY PRODUCTS BY USE, THROUGH 2016
  • Table 36 : MARKET ANALYSIS FOR ANTI-INFECTIVES BY USE, THROUGH 2016
  • Table 37 : MARKET ANALYSIS FOR ANTI-INFLAMMATORIES AND ANALGESICS BY USE, THROUGH 2016
  • Table 38 : MARKET ANALYSIS FOR METABOLIC DRUGS BY USE, THROUGH 2016
  • Table 39 : MARKET ANALYSIS FOR PARASITICIDES BY USE, THROUGH 2016
  • Table 40 : MARKET ANALYSIS FOR OTHER PHARMACEUTICALS BY USE, THROUGH 2016
  • Table 41 : MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL PRODUCTS BY USE, THROUGH 2016
  • Table 42 : MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL PRODUCTS BY TYPE, THROUGH 2016
  • Table 43 : DISTRIBUTION OF REVENUES FOR ANIMAL PHARMACEUTICALS BY WORLD REGION, 2011
  • Table 44 : COMPETITIVE SUMMARY FOR ANIMAL PHARMACEUTICAL PRODUCTS BY COMPETITOR REVENUES, 2011
  • Table 45 : AMINO ACIDS BY TARGET SPECIES AND PROVIDERS
  • Table 46 : MEDICINAL ADDITIVES BY TARGET SPECIES AND PROVIDERS
  • Table 47 : NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES AND PROVIDERS
  • Table 48 : VITAMINS AND MINERALS BY TARGET SPECIES AND PROVIDERS
  • Table 49 : MARKET ANALYSIS FOR AMINO ACIDS BY USE, THROUGH 2016
  • Table 50 : MARKET ANALYSIS FOR MEDICINAL FEED ADDITIVES BY USE, THROUGH 2016
  • Table 51 : MARKET ANALYSIS FOR NUTRITIONAL SUPPLEMENTS BY USE, THROUGH 2016
  • Table 52 : MARKET ANALYSIS FOR VITAMINS AND MINERALS BY USE, THROUGH 2016
  • Table 53 : MARKET ANALYSIS FOR ANIMAL FEED ADDITIVES BY USE, THROUGH 2016
  • Table 54 : MARKET ANALYSIS FOR ANIMAL FEED ADDITIVE PRODUCTS BY TYPE, THROUGH 2016
  • Table 55 : DISTRIBUTION OF REVENUES FOR ANIMAL FEED ADDITIVES BY WORLD REGION, 2011
  • Table 56 : COMPETITIVE SUMMARY FOR ANIMAL FEED ADDITIVES BY COMPETITOR REVENUES, 2011
  • Table 57 : DIAGNOSTICS BY TARGET SPECIES AND PROVIDERS
  • Table 58 : MARKET ANALYSIS FOR ANIMAL DIAGNOSTICS PRODUCTS BY USE, THROUGH 2016
  • Table 59 : REVENUES FOR ANIMAL DIAGNOSTICS BY TYPE, THROUGH 2016
  • Table 60 : REVENUES FOR RAPID DIAGNOSTICS BY TYPE (VETERINARY APPLICATIONS), THROUGH 2016
  • Table 61 : REVENUES FOR DIAGNOSTIC ANALYZERS AND CONSUMABLES BY TYPE (VETERINARY APPLICATIONS), THROUGH 2016
  • Table 62 : DISTRIBUTION OF REVENUES FOR ANIMAL DIAGNOSTICS BY WORLD REGION, 2011
  • Table 63 : COMPETITIVE SUMMARY FOR ANIMAL DIAGNOSTICS BY COMPETITOR REVENUES, 2011
  • Table 64 : TOTAL MARKET ANALYSIS FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY PRODUCT SEGMENT, THROUGH 2016
  • Table 65 : TOTAL MARKET ANALYSIS FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY ANIMAL TYPE, THROUGH 2016
  • Table 66 : DISTRIBUTION OF REVENUES FOR ANIMAL THERPEUTICS AND DIAGNOSTICS BY WORLD REGION, 2011
  • Table 67 : MAJOR INDUSTRY PARTICIPANTS BY PRODUCT TYPE
  • Table 68 : TOTAL COMPETITIVE MARKET SHARE FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY MANUFACTURER REVENUES, 2011
  • Table 69 : COMPETITOR MARKET POSITION - ANIMAL THERAPEUTICS AND DIAGNOSTICS BY MANUFACTURER REVENUES, 2011

List of Figures

  • Summary Figure : TOTAL ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY MAJOR SEGMENT, 2008-2016
  • Figure 1 : DOG (CANINE) POPULATION - TOP 10 COUNTRIES, 2010
  • Figure 2 : CAT (FELINE) POPULATION - TOP 10 COUNTRIES, 2010
  • Figure 3 : HORSE (EQUINE) POPULATION - TOP 10 COUNTRIES, 2010
  • Figure 4 : CATTLE (BOVINE) POPULATION - TOP 10 COUNTRIES, 2010
  • Figure 5 : PIG/HOG (SWINE) POPULATION - TOP 10 COUNTRIES, 2010
  • Figure 6 : SHEEP/LAMB POPULATION - TOP 10 COUNTRIES, 2010
  • Figure 7 : GOAT POPULATION - TOP 10 COUNTRIES, 2010
  • Figure 8 : ESTIMATED NUMBER OF VETERINARIAN'S IN THE UNITED STATES BY YEAR, 2007-2011
  • Figure 9 : MARKET ANALYSIS FOR ANIMAL VACCINES BY USE, 2008-2016
  • Figure 10 : ESTIMATED REVENUES FOR ANIMAL VACCINES BY TYPE, 2008-2016
  • Figure 11 : DISTRIBUTION OF REVENUES FOR ANIMAL VACCINES BY WORLD REGION, 2011
  • Figure 12 : COMPETITIVE SUMMARY FOR ANIMAL VACCINES BY COMPETITOR REVENUE, 2011
  • Figure 13 : MARKET ANALYSIS FOR ALLERGY AND RESPIRATORY PRODUCTS BY USE, 2008-2016
  • Figure 14 : MARKET ANALYSIS FOR ANTI-INFECTIVES BY USE, 2008-2016
  • Figure 15 : MARKET ANALYSIS FOR ANTI-INFLAMMATORIES AND ANALGESICS BY USE, 2008-2016
  • Figure 16 : MARKET ANALYSIS FOR METABOLIC DRUGS BY USE, 2008-2016
  • Figure 17 : MARKET ANALYSIS FOR PARASITICIDES BY USE, 2008-2016
  • Figure 18 : MARKET ANALYSIS FOR OTHER PHARMACEUTICALS BY USE, 2008-2016
  • Figure 19 : MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL PRODUCTS BY USE, 2008-2016
  • Figure 20 : MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL PRODUCTS BY TYPE, 2008-2016
  • Figure 21 : DISTRIBUTION OF REVENUES FOR ANIMAL PHARMACEUTICALS BY WORLD REGION, 2011
  • Figure 22 : COMPETITIVE SUMMARY FOR ANIMAL PHARMACEUTICAL PRODUCTS BY COMPETITOR REVENUES, 2011
  • Figure 23 : MARKET ANALYSIS FOR AMINO ACIDS BY USE, 2008-2016
  • Figure 24 : MARKET ANALYSIS FOR MEDICINAL FEED ADDITIVES BY USE, 2008-2016
  • Figure 25 : MARKET ANALYSIS FOR NUTRITIONAL SUPPLEMENTS BY USE, 2008-2016
  • Figure 26 : MARKET ANALYSIS FOR VITAMINS AND MINERALS BY USE, 2008-2016
  • Figure 27 : MARKET ANALYSIS FOR ANIMAL FEED ADDITIVES BY USE, 2008-2016
  • Figure 28 : MARKET ANALYSIS FOR ANIMAL FEED ADDITIVE PRODUCTS BY TYPE, 2008-2016
  • Figure 29 : DISTRIBUTION OF REVENUES FOR ANIMAL FEED ADDITIVES BY WORLD REGION, 2011
  • Figure 30 : COMPETITIVE SUMMARY FOR ANIMAL FEED ADDITIVES BY COMPETITOR REVENUES, 2011
  • Figure 31 : MARKET ANALYSIS FOR ANIMAL DIAGNOSTICS PRODUCTS BY USE, 2008-2016
  • Figure 32 : REVENUES FOR ANIMAL DIAGNOSTICS BY TYPE, 2008-2016
  • Figure 33 : REVENUES FOR RAPID DIAGNOSTICS BY TYPE (VETERINARY APPLICATIONS), 2008-2016
  • Figure 34 : REVENUES FOR DIAGNOSTIC ANALYZERS AND CONSUMABLES BY TYPE (VETERINARY APPLICATIONS), 2008-2016
  • Figure 35 : DISTRIBUTION OF REVENUES FOR ANIMAL DIAGNOSTICS BY WORLD REGION, 2011
  • Figure 36 : COMPETITIVE SUMMARY FOR ANIMAL DIAGNOSTICS BY COMPETITOR REVENUES, 2011
  • Figure 37 : TOTAL MARKET ANALYSIS FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY PRODUCT SEGMENT, 2008-2016
  • Figure 38 : TOTAL MARKET ANALYSIS FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY ANIMAL TYPE, 2008-2016
  • Figure 39 : DISTRIBUTION OF REVENUES FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY WORLD REGION, 2011
  • Figure 40 : TOTAL COMPETITIVE SUMMARY FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY COMPETITOR REVENUES, 2011
Back to Top